{
    "Trade/Device Name(s)": [
        "ImmunoCAP Specific IgE",
        "ImmunoCAP Allergen f439, Allergen component rCor a 14, Hazelnut, 14-5754-01",
        "ImmunoCAP Allergen f440, Allergen component nCor a 9, Hazelnut, 14-5758-01",
        "ImmunoCAP Allergen f441, Allergen component rJug r 1, Walnut, 14-5762-01",
        "ImmunoCAP Allergen f442, Allergen component rJug r 3, LTP, Walnut, 14-5954-01",
        "ImmunoCAP Allergen f443, Allergen component rAna o 3, Cashew nut, 14-5760-01"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "K150854",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051218",
        "K962274",
        "K974580"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "November 13, 2015",
    "Summary Letter Received Date": "November 16, 2015",
    "Submission Date": "December 9, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "IgE",
        "rCor a 14 (Hazelnut)",
        "nCor a 9 (Hazelnut)",
        "rJug r 1 (Walnut)",
        "rJug r 3, LTP (Walnut)",
        "rAna o 3 (Cashew nut)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Na-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated immunoassay",
        "Enzyme immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Quantitative IgE measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Phadia ImmunoCAP Specific IgE assay and five new allergen components for automated quantitative measurement of allergen-specific IgE in serum or plasma.",
    "Indications for Use Summary": "In vitro quantitative assay for measurement of allergen specific IgE in human serum or plasma (EDTA or Na-Heparin), used as an aid in clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings in clinical laboratories.",
    "fda_folder": "Immunology"
}